This is consistent with a previous study using human gastrointestinal stromal tumour xenografts that reported dose-limiting toxicities including 21% of body weight loss, skin dehydration, diarrhea, and histopathological changes in the spleen and small bowel following 12 days of continuous treatment with 10???mg/kg LBH589 [19].